Display options
Cite
Latov N, Gorson KC, Brannagan TH, et al. Diagnosis and Treatment of Chronic Immune-mediated Neuropathies. J Clin Neuromuscul Dis. 2006;7(3):141-57doi: 10.1097/01.cnd.0000205575.26451.e4.
Latov, N., Gorson, K. C., Brannagan, T. H., Freeman, R. L., Apostolski, S., Berger, A. R., Bradley, W. G., Briani, C., Bril, V., Busis, N. A., Cros, D. P., Dalakas, M. C., Donofrio, P. D., Dyck, P. J., England, J. D., Fisher, M. A., Herrmann, D. N., Menkes, D. L., Sahenk, Z., Sander, H. W., Triggs, W. J., & Vallat, J. M. (2006). Diagnosis and Treatment of Chronic Immune-mediated Neuropathies. Journal of clinical neuromuscular disease, 7(3), 141-57. https://doi.org/10.1097/01.cnd.0000205575.26451.e4
Latov, Norman, et al. "Diagnosis and Treatment of Chronic Immune-mediated Neuropathies." Journal of clinical neuromuscular disease vol. 7,3 (2006): 141-57. doi: https://doi.org/10.1097/01.cnd.0000205575.26451.e4
Latov N, Gorson KC, Brannagan TH, Freeman RL, Apostolski S, Berger AR, Bradley WG, Briani C, Bril V, Busis NA, Cros DP, Dalakas MC, Donofrio PD, Dyck PJ, England JD, Fisher MA, Herrmann DN, Menkes DL, Sahenk Z, Sander HW, Triggs WJ, Vallat JM. Diagnosis and Treatment of Chronic Immune-mediated Neuropathies. J Clin Neuromuscul Dis. 2006 Mar;7(3):141-57. doi: 10.1097/01.cnd.0000205575.26451.e4. PMID: 19078800.
Copy Download .nbib Format: NLM
Share it on

J Clin Neuromuscul Dis. 2006 Mar;7(3):141-57. doi: 10.1097/01.cnd.0000205575.26451.e4.

Diagnosis and Treatment of Chronic Immune-mediated Neuropathies.

Journal of clinical neuromuscular disease

Norman Latov, Kenneth C Gorson, Thomas H Brannagan, Roy L Freeman, Slobodan Apostolski, Alan R Berger, Walter G Bradley, Chiara Briani, Vera Bril, Neil A Busis, Didier P Cros, Marinos C Dalakas, Peter D Donofrio, P James B Dyck, John D England, Morris A Fisher, David N Herrmann, Daniel L Menkes, Zarife Sahenk, Howard W Sander, William J Triggs, Jean Michel Vallat

Affiliations

  1. Weill Medical College of Cornell University, NY

PMID: 19078800 DOI: 10.1097/01.cnd.0000205575.26451.e4

Abstract

The chronic autoimmune neuropathies are a diverse group of disorders, whose diagnosis and classification is based on the clinical presentations and results of ancillary tests. In chronic inflammatory demyelinating polyneuropathy, controlled therapeutic trials demonstrated efficacy for intravenous gamma-globulins, corticosteroids, and plasmaphereis. In multifocal motor neuropathy, intravenous gamma-globulins have been shown to be effective. In the other immune-mediated neuropathies, there are no reported controlled therapeutic trials, but efficacy has been reported for some treatments in non-controlled trials on case studies. Choice of therapy in individual cases is based on reported efficacy, as well as severity, progression, coexisting illness, predisposition to developing complications, and potential drug interactions.

Publication Types